http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106834462-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
| filingDate | 2017-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106834462-B |
| titleOfInvention | Application of gastric cancer genes |
| abstract | Application of a group of gastric cancer related genes. The invention calculates the prediction score to evaluate the clinical prognosis of gastric cancer and the related application thereof based on the detection results of a group of 53 prognosis related genes in gastric cancer and the expression level thereof in clinical samples. The system can be used for helping the treatment selection of the gastric cancer patient and predicting the response to treatment intervention, thereby judging whether the patient benefits from chemical and targeted treatment, avoiding excessive medication, reducing the medical cost and finally achieving the aim of precise or individualized medical treatment. According to the system and different detection technology platforms, a corresponding 53 gene expression measurement kit is designed and developed. |
| priorityDate | 2016-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 378.